glp-1 administration and Anesthesia: Considerations and Cautions for CRNAs NimbleRx I How to Prevent

Tirzepatide, a dual GIP/GLP-1 receptor co-agonist, also demonstrated significant efficacy in a phase II trial for MASH [6]

Patients should contact their GP or prescribing clinician if they experience persistent or worsening injection site reactions, including spreading redness, warmth, increasing pain, or purulent discharge, which may indicate infection or cellulitis requiring antimicrobial treatment

Working with Your Healthcare Team for Safe GLP-1 Use Before initiating GLP-1 therapy, schedule a consultation with your endocrinologist and primary care physician

Brewis, M., Poskanzer, D

A microfabricated multi-compartment device for neuron and Schwann cell differentiation